期刊文献+

尼可地尔缓释骨架片的制备 被引量:1

Preparation of nicorandil sustained release matrix tablets
下载PDF
导出
摘要 目的制备尼可地尔缓释骨架片。方法采用亲水性高分子材料HPMC为骨架,制备尼可地尔缓释片,并用单因素试验考察其释药特征。正交试验优化处方工艺。结果以60%HPMC K100M为骨架材料,磷酸氢钙为填充剂,用10%PVP的乙醇溶液为黏合剂,湿法制粒压片为最佳工艺。结论本品制备工艺简便,药物体外释放接近Higuchi模型,能实现药物24 h内缓慢释放。 Objective To prepare nicorandil sustained release matrix tablets. Methods The tablets were prepared by water soluble HPMC matrix, and the release behaviors were investigated by single factor study. The formulation and preparation procedure were optimized by orthogonal design. Results The optimal technology was as follows: 60%HPMC K100 M was used as the matrix material, calcium hydrogen phosphate as the filler, and 10% PVP of alcohol as the bonding agent to prepare nicorandil sustained release matrix tablets by the wet granule compression technique. Conclusion The release in vitro of the drug accords with Higuchi equation. This preparation technol ogy is simple and drug releases within 24 h.
作者 徐斌
出处 《中南药学》 CAS 2015年第3期273-276,共4页 Central South Pharmacy
关键词 尼可地尔 缓释骨架片 制备 nicorandil sustained release matrix tablet preparation
  • 相关文献

参考文献9

  • 1Hiroyuki M,Yutaka O,Masato I,et al.Formulation Approach for nicorandil pulsatile release tablet[J].Chem Pharm Bull,2008,56(4):464-467.
  • 2Abdelbary GA,Tadros MI.Design and in vitro/in vivo evaluation of novel nicorandil extended release matrix tablets based on hydrophilic interpolymer complexes and a hydrophobic waxy polymer[J].Eur J Pharm Biopharm,2008,69(1):1019-1028.
  • 3Rahman N,Khan NA,Hejaz Azmi SN.Optimized and validated spectrophotometric methods for the determination of nicorandil in drug formulations and biological fluids[J].Farmaco,2004,59(2):519-527.
  • 4王思鸿,陈坚平.格列喹酮缓释片的研制及其体外释放度考察[J].中南药学,2008,6(3):283-285. 被引量:4
  • 5宋金春,丁周凤.琥乙红霉素缓释片的处方工艺及其对释放度影响的研究[J].中国药师,2011,14(11):1609-1612. 被引量:2
  • 6Shamma RN,Basalious EB,Shoukr i RA.Development and optimization of a multiple-unit controlled release formulation of a freely water soluble drug for once-daily administration[J].Int J Pharm,2011,405(1):102-112.
  • 7Li CL,Martini LG,Ford JL,et al.The use of hypromellose in oral drug delivery[J].J Pharm Pharmacol,2005,57(5):533-546.
  • 8Siepmann J,Peppas NA.Modeling of drug release from delivery systems based on hydroxypropyl met hylcellulose(HPMC)[J].Adv Drug Deliv Rev,2 001,48(2):139-157.
  • 9Tamilvanan S,Venkatesh Babu R,Nappinai A,et al.In vitro and in vivo evaluation of hydrophilic and hydrophobic polymers-based nicorandil-loaded peroral tablet compared with its once-daily commercial sustained-release tablet[J].Drug Dev Ind Pharm,2011,37(4):436-445.

二级参考文献13

共引文献4

同被引文献7

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部